David Koditek

816 total citations
8 papers, 254 citations indexed

About

David Koditek is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, David Koditek has authored 8 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Organic Chemistry. Recurrent topics in David Koditek's work include PI3K/AKT/mTOR signaling in cancer (3 papers), HIV/AIDS drug development and treatment (2 papers) and HIV Research and Treatment (1 paper). David Koditek is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), HIV/AIDS drug development and treatment (2 papers) and HIV Research and Treatment (1 paper). David Koditek collaborates with scholars based in United States, United Kingdom and China. David Koditek's co-authors include Mary E. McGrath, Armando G. Villaseñor, John R. Somoza, Latesh Lad, Weimei Xing, Leanna Lagpacan, Dharmaraj Samuel, Ruth Wang, Melanie Wong and Nikolai Novikov and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

David Koditek

8 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Koditek United States	7	167	96	59	47	29	8	254
Pratistha Ranjitkar United States	8	215 1.3×	101 1.1×	39 0.7×	31 0.7×	71 2.4×	17	395
Mickael Mogemark Sweden	10	214 1.3×	136 1.4×	43 0.7×	11 0.2×	31 1.1×	16	262
Deheng Sun China	11	175 1.0×	121 1.3×	21 0.4×	36 0.8×	76 2.6×	18	311
Minhao Huang China	10	197 1.2×	121 1.3×	21 0.4×	16 0.3×	82 2.8×	19	337
Tisha San Miguel United States	9	154 0.9×	92 1.0×	17 0.3×	23 0.5×	26 0.9×	13	219
Dean Messing United States	10	139 0.8×	62 0.6×	13 0.2×	16 0.3×	55 1.9×	14	281
Martina Fitzek United Kingdom	8	213 1.3×	91 0.9×	33 0.6×	5 0.1×	45 1.6×	21	369
Ann Qin United States	11	81 0.5×	17 0.2×	33 0.6×	22 0.5×	79 2.7×	23	267
Su-Jun Deng United States	6	186 1.1×	47 0.5×	11 0.2×	23 0.5×	30 1.0×	7	399
Andrea A. Romeo Switzerland	8	228 1.4×	17 0.2×	24 0.4×	12 0.3×	53 1.8×	13	357

Countries citing papers authored by David Koditek

Since Specialization

Citations

This map shows the geographic impact of David Koditek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Koditek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Koditek more than expected).

Fields of papers citing papers by David Koditek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Koditek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Koditek. The network helps show where David Koditek may publish in the future.

Co-authorship network of co-authors of David Koditek

This figure shows the co-authorship network connecting the top 25 collaborators of David Koditek. A scholar is included among the top collaborators of David Koditek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Koditek. David Koditek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Perreault, Stéphane, Jayaraman Chandrasekhar, Hao Jia, et al.. (2020). Discovery of an Atropisomeric PI3Kβ Selective Inhibitor through Optimization of the Hinge Binding Motif. ACS Medicinal Chemistry Letters. 11(6). 1236–1243. 13 indexed citations

Chandrasekhar, Jayaraman, Ryan A. Dick, David Koditek, et al.. (2018). Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor. Journal of Medicinal Chemistry. 61(15). 6858–6868. 48 indexed citations

Perreault, Stéphane, Jayaraman Chandrasekhar, Zhi-Hua Cui, et al.. (2017). Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856. Journal of Medicinal Chemistry. 60(4). 1555–1567. 27 indexed citations

Somoza, John R., David Koditek, Armando G. Villaseñor, et al.. (2015). Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ. Journal of Biological Chemistry. 290(13). 8439–8446. 119 indexed citations

Lad, Latesh, Sheila Clancy, David Koditek, et al.. (2015). Functional Label-Free Assays for Characterizing the in Vitro Mechanism of Action of Small Molecule Modulators of Capsid Assembly. Biochemistry. 54(13). 2240–2248. 7 indexed citations

Huynh, Q K, Sarah Wise, Keith A. Koch, et al.. (2011). Screening and Identification of a Novel Class of TGF-β Type 1 Receptor Kinase Inhibitor. SLAS DISCOVERY. 16(7). 724–733. 6 indexed citations

Berry, Katherine E., Betty Peng, David Koditek, et al.. (2011). Optimized High-Throughput Screen for Hepatitis C Virus Translation Inhibitors. SLAS DISCOVERY. 16(2). 211–220. 8 indexed citations

Monovich, Lauren G., Keith A. Koch, Daniel Wall, et al.. (2009). Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1789(5). 422–431. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact